Immunology claims with experimental links

Unifying mechanism: time-dependent immune “re-tuning” from infection → cancer

Your statement proposes a single unifying mechanism: chronic immunomodulation reduces pathogen control and simultaneously erodes anti-tumor immunity. Below, I separate what is directly evidenced by the provided sources from what remains mechanistically plausible but not proven.

Mechanism map (known + inference)

Evidence basis for nodes: infection datasets show interferon-associated ADAR1 upregulation and RNA editing changes Congenital infection ADAR1 edits. CEI quantifies ADAR1p150-dependent cytoplasmic A-to-I editing responsive to interferon CEI is IFN/ADAR1p150 responsive. Tumor immune pressure with exhaustion signatures can be functionally reshaped; LIGHT+CTLA-4 reduces exhaustion markers Reduced exhaustion with LIGHT+CTLA-4. TRM vs TEX states separate survival vs ICB-linked dysfunction TRM vs TEX in tumors.
What remains inference: the temporal coupling “infection-program → later cancer exhaustion/TME editing failure” is a plausible unifying hypothesis, but these sources do not provide a single longitudinal causal chain from infection to malignancy exhaustion.

RNA editing scale in human cancer cohorts (ADAR-mediated context)

Example counts are reported from TCGA-based analyses summarized in a review of ADAR (A-to-I) and APOBEC (C-to-U) RNA editing codes TCGA editing site counts (review).
Note: this figure is not a causality claim; it quantifies that RNA editing landscapes are large-scale in human cancers.

Infection vs malignancy: immediate reactivation vs longer-term exhaustion (supported parallels)

Infection node: congenital CMV/ZIKV infection reprograms ADAR1 expression and A-to-I editing, consistent with rapid interferon-driven RNA editing changes Infection-associated ADAR1 upregulation.
Malignancy node: tumor contexts exhibit clonally distinct TRM vs TEX programs with differential outcome association; LIGHT+CTLA-4 can reduce exhaustion markers in MSS CRC metastasis models TRM vs TEX outcomes LIGHT+CTLA-4 decreases exhaustion markers.
Again: the figure encodes where evidence exists, not numerical magnitude.

Reversing chronic exhaustion signatures can accompany strong tumor control (example)

Directional effects are described in the manuscript summary provided: LIGHT+CTLA-4 increases TIL activation/infiltration, TLS formation, and DC maturation, while reducing exhaustion markers and suppressive myeloid populations LIGHT+CTLA-4 reshapes TME & exhaustion.
Mechanistic relevance: this supports the “longer-term immune erosion” component of the unifying mechanism by showing exhaustion signatures can be reduced when the chronic tumor microenvironment pressures are countered.

Epigenetic re-wiring can associate with immune microenvironment stimulation (example)

This is not an outcome plot; it simply visualizes reported multi-cohort breadth for an example where HDAC1/2 inhibition is linked to immune microenvironment remodeling in HCC HDAC1/2 inhibition linked to immune remodeling.

Skeptical evaluation (what’s strong vs uncertain)

• Strongly supported pieces: (i) infection contexts can upregulate ADAR1/ADAR1p150 and change A-to-I editing landscapes Infection-linked ADAR1 editing ; (ii) tumor immune pressure is associated with exhausted-like programs and their marker signatures TEX program distinctness ; (iii) microenvironment reprogramming (e.g., LIGHT+CTLA-4) can reduce exhaustion signatures and improve tumor control Exhaustion reduction with TME reprogramming.
• Uncertain coupling: the provided sources do not directly prove a single longitudinal mechanism in which infection-driven RNA editing dysregulation deterministically causes later tumor exhaustion/TME “editing failure”. The link is mechanistically plausible, but causal chain evidence would require time-resolved human cohorts or rigorous longitudinal models.
• Confounding risks: observational cancer cohorts (TCGA-like) and bulk tissue measurements can mix cell types and change with interferon states independent of tumor “editing failure”. RNA-editing calling can include technical artifacts; the review explicitly notes validation challenges and context dependence RNA editing detection caveats.

Explore deeper on BGPT